Neurol. praxi. 2025;26(5):436-442

A Colonial Briton from Denmark Hill: Charles David Marsden (1938-1998)

prof. MUDr. Petr Kaňovský, CSc., FEAN
Neurologická klinika a Centrum klinických neurověd Lékařské fakulty Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc

Charles David Marsden (1938-1998) was a British neurologist, one of the founders of the subspeciality of movement disorders for which the Czech language prefers to use the term "extrapyramidal diseases". He graduated from St Thomas's Hospital Medical School in London and began his career at Queen Square Neurological Hospital. However, he soon changed jobs and became a doctor at another NHS trust, Maudsley and Bethlem Royal Hospital and King's College Hospital, which were nicknamed "Denmark Hill" due to their location in London. Here, he established a centre that became the benchmark in the field of European neuroscience research for a long time; Marsden laboratories at Windsor Walk were deeply involved in experimental and clinical neuropharmacology, neurophysiology, neuropsychology, and neuropathology. In the late 1980s, the highly successful Marsden is offered the position of head of The National Hospital for Neurology and Neurosurgery in London, affiliated with University College of London (UCL), and Marsden returns to where his career began. At both Denmark Hill and Queen Square, Marsden created an inspiring environment where residents and fellows from all over the world kept coming to study neurology and neuroscience. In 1995, he was appointed dean of the UCL Institute of Neurology. After completing his three-year term, he took a one-year sabbatical, which he planned to spend at the NINDS in Bethesda. After having spent four weeks there, he died unexpectedly from coronary disease on 29 September 1998.

Keywords: Charles David Marsden, dystonia, motor control.

Published: November 6, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňovský P. A Colonial Briton from Denmark Hill: Charles David Marsden (1938-1998). Neurol. praxi. 2025;26(5):436-442.
Download citation

References

  1. Abbruzzese G, Berardelli A. Sensorimotor integration in movement disorders. Mov Disord. 2003;18:231-240. Go to original source... Go to PubMed...
  2. Alexandre GE, Critcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266-271. Go to original source... Go to PubMed...
  3. Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985;108:593-608. Go to original source... Go to PubMed...
  4. Bundey S, Harrison MJG, Marsden CD. A genetic study of torsion dystonia. J Med Genet. 1975;12:12-24. Go to original source... Go to PubMed...
  5. Denny Brown D. The midbrain and motor integration. Proc R Soc Med. 1962;55:527-530. Go to original source... Go to PubMed...
  6. Denny Brown D. Diseases of the basal ganglia: their relation to disorders of movement. Lancet. 1960;2(7161):1155-1162. Go to original source... Go to PubMed...
  7. Dick JPR, Cantello R, Buruma O, Gioux M, Benecke R, Day BL, Rothwell JC, Thompson PD, Marsden CD. The Bereitschaftspotential, L DOPA and Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1987;66:263-274. Go to original source... Go to PubMed...
  8. Dressler D, Altenmüller E, Krauss J. Treatment of dystonia. Cambridge University Press. 2018. Go to original source...
  9. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatr. 1986;49:381-389. Go to original source... Go to PubMed...
  10. Goetz CG, Ghiey A. The Movement Disorder Society and Movement Disorders: a modern history. Mov Disord. 2011;26:939-946. Go to original source... Go to PubMed...
  11. Jinnah H, Bhatia K, Albanese A, et al. International Review of Neurobiology: Dystonia. Elsevier. 2023.
  12. Kaňovský P. Dystonia: a disorder of motor programming or motor execution?. Mov Disord. 2002;17:1143-1147. Go to original source... Go to PubMed...
  13. Kaňovský P, Rosales R. Debunking the pathophysiological puzzle of dystonia: with special reference to botulinum toxin therapy. Park Relat Disord. 2011;17(Suppl S11):S11-S14. Go to original source... Go to PubMed...
  14. Kaňovský P, Bhatia KP, Rosales R, et al. Dystonia and dystonic syndromes. Springer Verlag. 2015. Go to original source...
  15. Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic induced parkinsonism. Brain. 1997;120:75-90. Go to original source... Go to PubMed...
  16. Manfredi M, Teive HA, Pedace F, Andrade LAF, Ferraz HB, Sá DS, Curra A. C. David Marsden and Rolex sign. Neurol Sci. 2003;24:45-46. Go to original source... Go to PubMed...
  17. Marsden CD. Pigmentation in the nucleus substantiae nigrae of mammals. J Anat. 1961;95:256-261.
  18. Marsden CD. Histochemical demonstration of ascorbic acid in the substantia nigra of the cat. Nature. 1962;193:787-788. Go to original source... Go to PubMed...
  19. Marsden CD, Rowland R. The mammalian pons, olive and pyramid. J Comp Neurol. 1962;124:175-187. Go to original source... Go to PubMed...
  20. Marsden CD. The development of pigmentation and enzyme activity in the nucleus substantiae nigrae of the cat. J Anat. 1965;99:175-180.
  21. Marsden CD. Drug treatment of diseases characterised by abnormal movements. Proc R Soc Med. 1973;66:871 873. Go to original source... Go to PubMed...
  22. Marsden CD. Neurology and psychiatry. Psychol Med. 1973;3:265-266. Go to original source... Go to PubMed...
  23. Marsden CD, Harrison MJG. Idiopathic torsion dystonia (dystonia musculorum deformans): a review of forty two patients. Brain. 1974;97:793-810. Go to original source... Go to PubMed...
  24. Marsden CD. Dystonia: the spectrum of the disease. In: Yahr MD, ed. Basal Ganglia. Raven Press. 1976:351-372.
  25. Marsden CD, Harrison MJG, Bundey S. Natural history of idiopathic torsion dystonia. In: Eldridge R, Fahn S, eds. Adv Neurol. 1976;14:177-186.
  26. Marsden CD. Problem of adult onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia). In: Eldridge R, Fahn S, eds. Adv Neurol. 1976;14:259-281.
  27. Marsden CD. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome): a variant of adult onset torsion dystonia. J Neurol Neurosurg Psychiatr. 1976;39:1204-1209. Go to original source... Go to PubMed...
  28. Marsden CD. "ON OFF" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1976;1(7954):292-296. Go to original source... Go to PubMed...
  29. Marsden CD, Merton PA, Morton HB, Adam JER. Feedback control of voluntary movements in man. In: Cobb WA, Van Duijn H, eds. Contemp Clin Neurophysiol (EEG Suppl 34). Elsevier. 1978:507-510.
  30. Marsden CD, Schachter M. Assessment of extrapyramidal disorders. Br J Clin Pharmacol. 1981;11:129-151. Go to original source... Go to PubMed...
  31. Marsden CD, Sheehy MP. Spastic dysphonia, Meige disease and torsion dystonia. Neurology. 1982;32:1202-1203. Go to original source... Go to PubMed...
  32. Marsden CD. The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology. 1982;32:514-539. Go to original source... Go to PubMed...
  33. Marsden CD. Basal ganglia disease. Lancet. 1982;320(8308):1141-1147. Go to original source... Go to PubMed...
  34. Marsden CD, Marion MH, Quinn N. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatr. 1984;47:1166-1173. Go to original source... Go to PubMed...
  35. Marsden CD, Rothwell JC. The physiology of idiopathic dystonia. Can J Neurol Sci. 1987;14:52- 527. Go to original source... Go to PubMed...
  36. Marsden CD, Obeso JA. The functions of basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain. 1994;117:877-897. Go to original source... Go to PubMed...
  37. Menšíková K, Matěj R, Colosimo C, et al. Lewy body disease or diseases with Lewy bodies?. NPJ Parkinsons Dis. 2022;8:3. Go to original source... Go to PubMed...
  38. Obeso JA, Rothwell JC, Lang AE, Marsden CD. Myoclonic dystonia. Neurology. 1983;33:825-835. Go to original source... Go to PubMed...
  39. Owen AM, James M, Leigh PN, et al. Fronto striatal cognitive deficits at different stages of Parkinson's disease. Brain. 1992;115:1727-1751. Go to original source... Go to PubMed...
  40. Quinn NP, Rossor MN, Marsden CD. Dementia and Parkinson's disease: pathological and neurochemical considerations. Br Med Bull. 1986;42:86-90. Go to original source... Go to PubMed...
  41. Rauschenberger L, Knorr S, Pisani A, et al. Second hit hypothesis in dystonia: dysfunctional crosstalk between neuroplasticity and environment?. Neurobiol Dis. 2021;159:105511. Go to original source... Go to PubMed...
  42. Rondot P. The shadow of movement. J Neurol. 1991;238:411-419. Go to original source... Go to PubMed...
  43. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease and multiple system atrophy in test sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatr. 1994;57:79-88. Go to original source... Go to PubMed...
  44. Rothwell JC, Traub MM, Marsden CD. Primary writing tremor. J Neurol Neurosurg Psychiatr. 1979;42:1106-1114. Go to original source... Go to PubMed...
  45. Sheehy MP, Marsden CD. Writer's cramp: a focal dystonia. Brain. 1982;105:461-480. Go to original source... Go to PubMed...
  46. Spillane JD, Nathan PW, Kelly RE, Marsden CD. Painful legs and moving toes. Brain. 1971;94:541-556. Go to original source... Go to PubMed...
  47. Tinazzi M, Rosso T, Fiaschi A. Role of the somatosensory system in primary dystonia. Mov Disord. 2003;17:605-622. Go to original source... Go to PubMed...
  48. Vitek JL. Pathophysiology of dystonia: a neuronal model. Mov Disord. 2002;17(Suppl 2):S49-S62. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.